Ketotifen Fumarate | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Ketotifen Fumarate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

14 API Suppliers, 3 USDMF, 3 CEP/COS, 3 JDMF, 5 KDMF, 11 NDC API, 11 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

INTERMEDIATES

5 Intermediates Suppliers

5 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

60 FDF Dossiers, 9 FDA Orange Book, 24 Europe, 2 Canada, 7 South Africa, 18 Listed Dossiers

RELATED EXCIPIENT COMPANIES

5 Actylis, 1 Finar, 1 Kerry, 1 Pluviaendo

EXCIPIENTS BY APPLICATIONS

5 Parenteral, 2 Solubilizers, 1 Controlled & Modified Release, 1 Film Formers & Plasticizers, 1 Coating Systems & Additives, 1 Topical

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 10 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

18 Finished Drug Prices

18 Finished Drug Prices

MARKET PLACE

13 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 1 US Exclusivities

REF. STANDARDS & IMPURITIES

3 EDQM

3 EDQM

$ Xls

Filters

Filters

FILTER :

filter Company Name Reset all filters

1 All

01 1JOHNSON JOHNSON VISN

filter Product Reset all filters

filter Exclusivity Expiration Date Reset all filters

filter Exclusivity Code Reset all filters

Product Main Page

01

JOHNSON JOHNSON VISN

KETOTIFEN FUMARATE

Pharmtech & Ingredients

Not Confirmed

Contact us
to update this info